Base Carbon Announces Investor Call
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce the Company will host an investor update call on Tuesday, April 1, 2025, at 11:00 a.m. Eastern Time (EDT).
The Company intends to release the 2024 year-end financial results on Monday, March 31, 2025. The management team will provide a business update in connection with the results and respond to investor questions via Zoom Webinar. Registration instructions are published below. The Company invites current and prospective shareholders to attend this business update call and Q&A session.
DATE: Tuesday, April 1, 2025
TIME: 11:00 a.m. EDT
LOCATION: Zoom Webinar. To receive the meeting link and passcode, please register here.
QUESTIONS: Please submit questions ahead of time to: [email protected].
About Base Carbon
Base Carbon is a financier of projects involved primarily in the global voluntary carbon markets. We endeavor to be the preferred carbon project partner in providing capital and management resources to carbon removal and abatement projects globally and, where appropriate, will utilize technologies within the evolving environmental industries to enhance efficiencies, commercial credibility, and trading transparency. For more information, please visit www.basecarbon.com.
Media and Investor Inquiries
Base Carbon Inc.
Investor Relations
Tel: +1 647 952 3979
E-mail: [email protected]
Media Inquiries
E-mail: [email protected]
Source: Base Carbon Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pure DC Launches One of Europe’s Largest Ever AI Infrastructure Projects: Phase 1 (110MW) of an over €7.5 Billion, 550MW AI Campus in Seinäjoki, Begins Fully Leased, with Planning & Power Already
- Wells Fargo climbs premarket after strong Q2 earnings beat
- Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share